PROB.ST Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 mai 2024 @ 10:23):

Stats
Dagens volum	25.00
Gjennomsnittsvolum	664.00
Markedsverdi	2.35B
EPS	SEK0 ( 2024-04-23 )
Neste inntjeningsdato	( SEK0 ) 2024-07-16
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	139.19
ATR14	SEK0 (0.00%)

Probi AB (publ) Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Probi AB (publ) Økonomi

Annual	2023
Omsetning:	SEK627.69M
Bruttogevinst:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2023
Omsetning:	SEK627.69M
Bruttogevinst:	SEK220.21M (35.08 %)
EPS:	SEK1.480

FY	2022
Omsetning:	SEK618.29M
Bruttogevinst:	SEK255.45M (41.32 %)
EPS:	SEK3.57

FY	2021
Omsetning:	SEK658.18M
Bruttogevinst:	SEK288.01M (43.76 %)
EPS:	SEK7.30

Financial Reports:

No articles found.

Probi AB (publ)

Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children's, women's, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks. The company sells its products approximately in 40 countries worldwide. It has a collaboration with Örebro University for research into exploration needle free vaccines; and a collaboration with La Trobe University to conduct a clinical trial to investigate the effect of Probi Osteo in an Australian women. The company was incorporated in 1991 and is headquartered in Lund, Sweden. Probi AB (publ) is a subsidiary of Symrise AG.